<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — November 2025]]></title><description><![CDATA[<p dir="auto">Danske kvartalsregnskaber: Nu gælder det <a href="https://proinvestor.com/boards/129367" rel="nofollow ugc">https://proinvestor.com/boards/129367</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400904/pharma-november-2025</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 22:24:20 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400904.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 03 Nov 2025 07:45:54 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — November 2025 on Thu, 27 Nov 2025 05:33:20 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck: Trækker sig fra budkamp og det er godt nyt <a href="https://proinvestor.com/boards/129996" rel="nofollow ugc">https://proinvestor.com/boards/129996</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038334</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038334</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 27 Nov 2025 05:33:20 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — November 2025 on Wed, 19 Nov 2025 11:07:06 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck: Er de havnet i en catch 22? <a href="https://proinvestor.com/boards/129852" rel="nofollow ugc">https://proinvestor.com/boards/129852</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038335</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038335</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 19 Nov 2025 11:07:06 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — November 2025 on Tue, 18 Nov 2025 09:37:05 GMT]]></title><description><![CDATA[<p dir="auto">Roche +6% i et ellers rødt marked. Phase 3 resultat</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038338</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038338</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Tue, 18 Nov 2025 09:37:05 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — November 2025 on Fri, 14 Nov 2025 11:13:11 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck tilbyder at købe irsk biotekselskab for op til 16 mia. kr. <a href="https://proinvestor.com/investornyt/1383127/lundbeck-tilbyder-at-kobe-irsk-biotekselskab-for-op-til-16-mia-kr" rel="nofollow ugc">https://proinvestor.com/investornyt/1383127/lundbeck-tilbyder-at-kobe-irsk-biotekselskab-for-op-til-16-mia-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038336</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038336</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 14 Nov 2025 11:13:11 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — November 2025 on Wed, 12 Nov 2025 16:05:50 GMT]]></title><description><![CDATA[<p dir="auto">ALK-Abellós europæiske tabletsalg leverer igen tocifret vækst <a href="https://proinvestor.com/investornyt/1382333/alk-abellos-europaeiske-tabletsalg-leverer-igen-tocifret-vaekst" rel="nofollow ugc">https://proinvestor.com/investornyt/1382333/alk-abellos-europaeiske-tabletsalg-leverer-igen-tocifret-vaekst</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038339</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038339</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 12 Nov 2025 16:05:50 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — November 2025 on Tue, 11 Nov 2025 14:45:53 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck opjusterer forventningerne <a href="https://proinvestor.com/investornyt/1381833/lundbeck-opjusterer-forventningerne" rel="nofollow ugc">https://proinvestor.com/investornyt/1381833/lundbeck-opjusterer-forventningerne</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038340</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038340</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 11 Nov 2025 14:45:53 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — November 2025 on Tue, 11 Nov 2025 05:40:56 GMT]]></title><description><![CDATA[<p dir="auto">OVERBLIK: Disse selskaber er shortet på det danske aktiemarked <a href="https://proinvestor.com/investornyt/1381698/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked" rel="nofollow ugc">https://proinvestor.com/investornyt/1381698/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038333</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038333</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 11 Nov 2025 05:40:56 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — November 2025 on Tue, 11 Nov 2025 04:57:41 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck får sænket anbefaling og kursmål skåret med en femtedel <a href="https://proinvestor.com/investornyt/1381681/lundbeck-far-saenket-anbefaling-og-kursmal-skaret-med-en-femtedel" rel="nofollow ugc">https://proinvestor.com/investornyt/1381681/lundbeck-far-saenket-anbefaling-og-kursmal-skaret-med-en-femtedel</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038337</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038337</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 11 Nov 2025 04:57:41 GMT</pubDate></item></channel></rss>